Superior Lethal Activity of Novel BET Protein Proteolysis Targeting Chimera (BETP-PROTACs®) Versus Betp Bromodomain Inhibitor (BETi) Against Post-Myeloproliferative Neoplasm (MPN) Secondary(s) AML Cells